Advertisement

Topics

Otsuka Buying Visterra for $430M

05:32 EDT 12 Jul 2018 | Contract Pharma

Hierotope platform enables design and engineering of next-generation antibody-based therapies

Original Article: Otsuka Buying Visterra for $430M

NEXT ARTICLE

More From BioPortfolio on "Otsuka Buying Visterra for $430M"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...